|
2024
|
Invention
|
Combination treatment of alzheimer's disease. The invention relates to the treatment of Alzheimer... |
|
2020
|
Invention
|
Edaravone salt. The invention relates to a salt of 3-methyl-1-phenyl-2-pyrazolin-5-one (edaravone... |
|
|
Invention
|
Use of edaravone in oral treatment of oxidative-stress mediated neurodegenerative disorders.
The... |
|
2019
|
Invention
|
Medical treatment comprising enteral administration of edaravone. A solid water-dispersible pharm... |
|
|
Invention
|
Treatment comprising oral or gastric administration of edaravone.
The invention relates to a liq... |
|
2018
|
Invention
|
Edaravone salt. The invention relates to a salt of 3-methyl-1 -phenyl-2-pyrazolin-5-one (edaravon... |
|
|
Invention
|
Use of edaravone in oral treatment of oxidative-stress mediated neurodegenerative disorders. The ... |
|
|
Invention
|
Treatment comprising oral or gastric administration of edaravone. The invention relates to a liqu... |
|
2017
|
G/S
|
medicines and pharmaceutical preparations for the treatment of neurodegenerative diseases; medici... |
|
|
Invention
|
Medical treatment comprising enteral administration of edaravone. The invention relates to a soli... |
